174 related articles for article (PubMed ID: 38150606)
21. Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life.
Locati LD; Galbiati D; Calareso G; Alfieri S; Singer S; Cavalieri S; Bergamini C; Bossi P; Orlandi E; Resteghini C; Platini F; Granata R; Quattrone P; Mancinelli M; Mariani L; Lo Vullo S; Licitra LF
Cancer; 2020 Jan; 126(9):1888-1894. PubMed ID: 32031693
[TBL] [Abstract][Full Text] [Related]
22. Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?
Alfieri S; Granata R; Bergamini C; Resteghini C; Bossi P; Licitra LF; Locati LD
Oral Oncol; 2017 Mar; 66():58-63. PubMed ID: 28249649
[TBL] [Abstract][Full Text] [Related]
23. Androgen receptor in salivary gland carcinoma: A review of an old marker as a possible new target.
Yeoh CC; Dabab N; Rigby E; Chhikara R; Akaev I; Gomez RS; Fonseca F; Brennan PA; Rahimi S
J Oral Pathol Med; 2018 Aug; 47(7):691-695. PubMed ID: 29863801
[TBL] [Abstract][Full Text] [Related]
24. Estrogen and progesterone receptors in salivary gland adenoid cystic carcinoma.
Shick PC; Riordan GP; Foss RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Oct; 80(4):440-4. PubMed ID: 8521108
[TBL] [Abstract][Full Text] [Related]
25. Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities?
Cavalieri S; Platini F; Bergamini C; Resteghini C; Galbiati D; Bossi P; Perrone F; Tamborini E; Quattrone P; Licitra L; Locati LD; Alfieri S
Expert Opin Investig Drugs; 2019 May; 28(5):435-443. PubMed ID: 30897975
[TBL] [Abstract][Full Text] [Related]
26. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
Agulnik M; Cohen EW; Cohen RB; Chen EX; Vokes EE; Hotte SJ; Winquist E; Laurie S; Hayes DN; Dancey JE; Brown S; Pond GR; Lorimer I; Daneshmand M; Ho J; Tsao MS; Siu LL
J Clin Oncol; 2007 Sep; 25(25):3978-84. PubMed ID: 17761983
[TBL] [Abstract][Full Text] [Related]
27. Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors.
Wong SJ; Karrison T; Hayes DN; Kies MS; Cullen KJ; Tanvetyanon T; Argiris A; Takebe N; Lim D; Saba NF; Worden FP; Gilbert J; Lenz HJ; Razak AR; Roberts JD; Vokes EE; Cohen EE
Ann Oncol; 2016 Feb; 27(2):318-23. PubMed ID: 26598548
[TBL] [Abstract][Full Text] [Related]
28. A molecular guide to systemic therapy in salivary gland carcinoma.
Weaver AN; Lakritz S; Mandair D; Ulanja MB; Bowles DW
Head Neck; 2023 May; 45(5):1315-1326. PubMed ID: 36859797
[TBL] [Abstract][Full Text] [Related]
29. Salivary gland cancers: biology and molecular targets for therapy.
Bell D; Hanna EY
Curr Oncol Rep; 2012 Apr; 14(2):166-74. PubMed ID: 22246609
[TBL] [Abstract][Full Text] [Related]
30. Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma.
Lee A; Givi B; Osborn VW; Schwartz D; Schreiber D
Laryngoscope; 2017 Sep; 127(9):2057-2062. PubMed ID: 28194862
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical localization of estradiol, progesterone, and progesterone receptor in human salivary glands and salivary adenoid cystic carcinomas.
Ozono S; Onozuka M; Sato K; Ito Y
Cell Struct Funct; 1992 Jun; 17(3):169-75. PubMed ID: 1322800
[TBL] [Abstract][Full Text] [Related]
32. Systemic therapy in the management of metastatic or advanced salivary gland cancers.
Lagha A; Chraiet N; Ayadi M; Krimi S; Allani B; Rifi H; Raies H; Mezlini A
Oral Oncol; 2012 Oct; 48(10):948-957. PubMed ID: 22698431
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of nelfinavir as monotherapy in refractory adenoid cystic carcinoma: Results of a phase II clinical trial.
Hoover AC; Milhem MM; Anderson CM; Sun W; Smith BJ; Hoffman HT; Buatti JM
Head Neck; 2015 May; 37(5):722-6. PubMed ID: 24596143
[TBL] [Abstract][Full Text] [Related]
34. [Ultrastructure of adenoid-cystic carcinoma as a sign of malignity (comparison of ultramicroscopical investigations concerning adenoid-cystic carcinoma and adeno-carcinoma of salivary glands) (author's transl)].
Bienengräber V
Arch Geschwulstforsch; 1981; 51(3):262-72. PubMed ID: 6268010
[TBL] [Abstract][Full Text] [Related]
35. Systemic therapy in the palliative management of advanced salivary gland cancers.
Laurie SA; Licitra L
J Clin Oncol; 2006 Jun; 24(17):2673-8. PubMed ID: 16763282
[TBL] [Abstract][Full Text] [Related]
36. Salivary gland carcinoma: Towards a more personalised approach.
Rached L; Saleh K; Casiraghi O; Even C
Cancer Treat Rev; 2024 Mar; 124():102697. PubMed ID: 38401478
[TBL] [Abstract][Full Text] [Related]
37. [Advances in the molecular mechanisms of perineural invasion in salivary adenoid cystic carcinoma].
Zhang M; Liang XH; Tang YL
Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Apr; 36(2):204-211. PubMed ID: 29779285
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands.
Ma B; Liang LZ; Liao GQ; Liang YJ; Liu HC; Zheng GS; Su YX
J Oral Pathol Med; 2013 Nov; 42(10):774-80. PubMed ID: 23590333
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic analysis of adenoid cystic carcinoma of major salivary glands of 64 cases].
Qing J; Zhang Q; Wei MW; Guo ZM
Ai Zheng; 2006 Sep; 25(9):1138-43. PubMed ID: 16965658
[TBL] [Abstract][Full Text] [Related]
40. Response to paclitaxel in adenoid cystic carcinoma of the salivary glands.
Till BG; Martins RG
Head Neck; 2008 Jun; 30(6):810-4. PubMed ID: 17979110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
